Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Winnergy Medical PCLBKK:WINMED +1.14%59 EBITDA Margin % is 13.65% as of Mar. 2026, which is 17% below its 10-year median of 16.47. GuruFocus rates BKK:WINMED with a GF Score™ of 59/100 and a GF Value™ of ฿1.86 (Possible Value Trap). The stock has 11 warning signs investors should review. Among 119 Medical Distribution companies, Winnergy Medical PCL ranks better than 86.55% on this metric.
Winnergy Medical PCL (BKK:WINMED) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Winnergy Medical PCL EBITDA Margin % Related Terms
Winnergy Medical PCL EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Winnergy Medical PCL's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:WINMED vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Winnergy Medical PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Winnergy Medical PCL EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Winnergy Medical PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Winnergy Medical PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Winnergy Medical PCL (BKK:WINMED) has a EBITDA Margin % of 13.65% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Winnergy Medical PCL and its competitors. This is 17% below median its historical median of 16.47. Over the past decade, Winnergy Medical PCL's EBITDA Margin % has ranged from 2.29 to 20.56. According to the industry distribution chart, Winnergy Medical PCL ranks #16 out of 119 companies in the Medical Distribution industry, placing it in the top 13.4%.
Is Winnergy Medical PCL's EBITDA Margin % too high?
Winnergy Medical PCL's current EBITDA Margin % of 13.65% is 17% below median its 10-year median of 16.47. Over the past 10 years, this metric has ranged from a low of 2.29 to a high of 20.56. The Medical Distribution industry median EBITDA Margin % is 4.11. Winnergy Medical PCL's value of 13.65% is 232.1% above this industry median. Based on the distribution chart, Winnergy Medical PCL ranks #16 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Winnergy Medical PCL has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Winnergy Medical PCL's EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Winnergy Medical PCL ranks #16 out of 119 companies for EBITDA Margin %. This places Winnergy Medical PCL in the top 13% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.11. Winnergy Medical PCL's value of 13.65% is 232.1% above this benchmark. Historically, Winnergy Medical PCL's own EBITDA Margin % has ranged from 2.29 to 20.56 over the past decade. While the company's 10-year median is 16.47 vs. the industry median of 4.11, Winnergy Medical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.11, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Winnergy Medical PCL's current EBITDA Margin % of 13.65% is 232.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Winnergy Medical PCL and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Winnergy Medical PCL's current EBITDA Margin % is 13.65%, which is 17% below median its own 10-year median of 16.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Winnergy Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Winnergy Medical PCL (BKK:WINMED) is currently considered Possible Value Trap. The stock's GF Value™ is ฿1.86, compared to a current price of ฿0.89 — trading 52.2% below its estimated fair value. The current EBITDA Margin % is 13.65%, which is 17% below median its 10-year median of 16.47 and 232.1% above the Medical Distribution industry median of 4.11. Winnergy Medical PCL's overall GF Score™ is 59/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Winnergy Medical PCL (BKK:WINMED), the current EBITDA Margin % is 13.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Winnergy Medical PCL (BKK:WINMED) Overvalued in 2026?
Based on GuruFocus' analysis, Winnergy Medical PCL stock appears to be undervalued.
The current stock price of ฿0.89 is trading 52.2% below its estimated GF Value™ of ฿1.86.
GuruFocus considers Winnergy Medical PCL to be Possible Value Trap.
Key valuation signals for BKK:WINMED:
EBITDA Margin %: 13.65% (17% below median its 10-year median of 16.47)
GF Value™: ฿1.86 vs. price of ฿0.89 (52.2% below fair value)
Industry Position: 232.1% above the Medical Distribution median (#16 of 119)
No single metric tells the full story. See the BKK:WINMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Winnergy Medical PCL is engaged in the distribution of medical and diagnostics equipment. Its businesses include the distribution of medical devices, chemicals, and medical equipment and technology. The company operates in the geographic area of Thailand.
59GF Score
Get the complete analysis for BKK:WINMED
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:WINMED has been successfully added to your 
